Clinical trial
The Effect of Treatment of Obstructive Sleep Apnea on Diabetes Self Management and Glycemic Control
NCT01901055 is registered in ClinicalTrials.gov with Eileen R. Chasens as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Treatment of Obstructive Sleep Apnea on Diabetes Self Management and Glycemic Control
- Lead sponsor
- Eileen R. Chasens
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 13, 2014
- Completion date
- May 8, 2019
- Enrollment
- 98 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
obstructive sleep apnea, type 2 diabetes